Medicenna Therapeutics (MDNA) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free MDNA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMedicenna reports advancement in cancer immunotherapyinvesting.com - April 11 at 9:15 AMMedicenna to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conferencefinance.yahoo.com - April 4 at 7:59 AMMedicenna Therapeutics Corp MDNAmorningstar.com - March 1 at 2:01 AMMedicenna Therapeutics Reports Third Quarter Fiscal 2024 Financial Results and Corporate Updatefinance.yahoo.com - February 14 at 10:05 AMMedicenna Announces Appointment of New Auditortmcnet.com - January 12 at 6:05 PMMedicenna Announces Trading on the OTCQB Under the Symbol MDNAFfinance.yahoo.com - December 19 at 7:23 AMMDNA.TO: Overall Survival Data from Phase 2b Trial of Bizaxofusp Presented at SNO 2023…finance.yahoo.com - November 20 at 5:51 PMMedicenna Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Operational Highlightsfinance.yahoo.com - November 14 at 10:03 AMMDNA.TO: Additional Confirmed PR in Phase 1/2 ABILITY Trial of MDNA11finance.yahoo.com - November 13 at 1:37 PMMedicenna Announces Promising Single-Agent Response and Durability of MDNA11 in the Phase 1/2 ABILITY Study During Dose Escalation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)finance.yahoo.com - November 6 at 7:57 AMMedicenna Presents Preclinical Data on MDNA113, its Targeted Metalloprotease Activated SuperKine (T-MASK) at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)finance.yahoo.com - November 3 at 1:37 PMWhy Is Medicenna Therapeutics (MDNA) Stock Down Today?msn.com - October 30 at 9:46 AMMedicenna Announces Nasdaq Delisting and Cutback of Management Teamfinance.yahoo.com - October 27 at 8:02 AMMedicenna Therapeutics Doses First Patient in Phase 2 Monotherapy Dose Expansion Portion of the ABILITY Study Evaluating MDNA11 in Select Types of Solid Tumorsfinance.yahoo.com - October 25 at 9:37 AMClosing Bell: Medicenna Therapeutics Corp up on Thursday (MDNA)theglobeandmail.com - October 13 at 12:40 PMMedicenna Therapeutics Names Humphrey Gardner CMOmarkets.businessinsider.com - October 10 at 8:13 AMMedicenna Therapeutics Appoints Humphrey Gardner, M.D., as Chief Medical Officerfinance.yahoo.com - October 10 at 8:13 AMMedicenna Announces Results of Annual and Special Meeting of Shareholdersfinance.yahoo.com - September 28 at 6:57 PMMedicenna Therapeutics (TSE:MDNA) Price Target Decreased by 12.14% to 3.94nasdaq.com - September 13 at 1:31 AMClosing Bell: Medicenna Therapeutics Corp flat on Monday (MDNA)theglobeandmail.com - August 22 at 11:51 AMMDNA: Commences Monotherapy Dose Expansion in Phase 1/2 ABILITY Trial…msn.com - August 15 at 4:46 PMThe Latest Analyst Ratings for Medicenna Therapeuticsmarkets.businessinsider.com - August 14 at 3:22 PMMedicenna Establishes Boston Presence, Appoints Brent Meadows as Chief Business Officer, and Bolsters Managementfinance.yahoo.com - August 14 at 7:20 AMMedicenna Therapeutics's Earnings: A Previewbenzinga.com - August 8 at 2:50 PMMedicenna Appoints Dr. Arash Yavari as Chair of Development Advisory Committeebenzinga.com - August 8 at 9:50 AMMedicenna Appoints Dr. Arash Yavari as Chair of Development Advisory Committeefinance.yahoo.com - August 8 at 9:50 AMMedicenna Therapeutics to Provide Clinical Update from Phase 1/2 ABILITY Study on August 9, 2023finance.yahoo.com - August 4 at 4:50 PMMedicenna Strengthens IP Portfolio with U.S. Patent Granted for the Use of Interleukin-2 Superkine Fusion Proteins in Oncologyfinance.yahoo.com - August 1 at 11:29 AMH.C. Wainwright Thinks Medicenna Therapeutics Corp’s Stock is Going to Recovermarkets.businessinsider.com - July 31 at 8:14 AMMedicenna Therapeutics Corp.: Medicenna Reports First Quarter Fiscal 2024 Financial Results and Operational Highlightsfinanznachrichten.de - July 28 at 10:14 AMMedicenna Reports First Quarter Fiscal 2024 Financial Results and Operational Highlightsfinance.yahoo.com - July 28 at 10:14 AMMedicenna Presents at National Brain Tumor Society's Research Round Tablefinance.yahoo.com - July 25 at 7:16 AMClosing Bell: Medicenna Therapeutics Corp down on Tuesday (MDNA)theglobeandmail.com - July 19 at 7:33 AMMDNA: Full MDNA11 Clinical Update in Calendar 3Q23…finance.yahoo.com - July 6 at 3:06 PMMedicenna Therapeutics Corp.: Medicenna Reports Fiscal Year 2023 Financial Results and Operational Highlightsfinanznachrichten.de - June 27 at 12:55 PMMedicenna Reports Fiscal Year 2023 Financial Results and Operational Highlightsfinance.yahoo.com - June 27 at 8:59 AMClosing Bell: Medicenna Therapeutics Corp down on Wednesday (MDNA)theglobeandmail.com - May 18 at 8:34 AMClosing Bell: Medicenna Therapeutics Corp down on Monday (MDNA)theglobeandmail.com - May 16 at 9:49 AMClosing Bell: Medicenna Therapeutics Corp flat on Friday (MDNA)theglobeandmail.com - May 6 at 10:21 AMClosing Bell: Medicenna Therapeutics Corp down on Friday (MDNA)theglobeandmail.com - April 29 at 8:48 AMMedicenna Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirementfinance.yahoo.com - April 27 at 7:57 AMClosing Bell: Medicenna Therapeutics Corp up on Friday (MDNA)theglobeandmail.com - April 22 at 8:22 AMMDNA: Update on ABILITY Trial…msn.com - April 19 at 4:01 PMHere's Why We're Not Too Worried About Medicenna Therapeutics' (TSE:MDNA) Cash Burn Situationfinance.yahoo.com - April 19 at 9:53 AMMedicenna to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conferencefinance.yahoo.com - April 18 at 9:25 AMMedicenna Presents Preclinical IL-13 Superkine Data at the AACR Annual Meetingfinance.yahoo.com - April 17 at 7:21 AMMedicenna Provides Clinical Update from Monotherapy Dose Escalation Portion of Phase 1/2 ABILITY Studyfinance.yahoo.com - March 30 at 8:45 AMMedicenna Announces Upcoming Presentation at the AACR Annual Meetingfinance.yahoo.com - March 15 at 8:31 AMMedicenna Therapeutics Corp.: Medicenna Reports Third Quarter Fiscal 2023 Financial Results and Operational Highlightsfinanznachrichten.de - February 7 at 2:01 PMMedicenna Reports Third Quarter Fiscal 2023 Financial Results and Operational Highlightsfinance.yahoo.com - February 7 at 8:55 AM Get Medicenna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. MDNA Media Mentions By Week MDNA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDNA News Sentiment▼0.000.46▲Average Medical News Sentiment MDNA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDNA Articles This Week▼00▲MDNA Articles Average Week Get Medicenna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RDHL News ERNA News PPBT News MIRA News ELAB News GHSI News ABVC News AGE News MBRX News ATHE News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDNA) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicenna Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
